Pharmaceuticals

Pharma Grade Cellulose Powder Market 2026–2030: Emerging Trends and Forecast Opportunities

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharma grade cellulose powder market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Pharma Grade Cellulose Powder Market between 2026 and 2030?

The market for pharma grade cellulose powder has experienced significant growth in recent years. Its valuation is set to rise from $1.55 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The primary drivers of this historical expansion include the increasing development of oral drug formulations, the broad adoption of cellulose excipients, the growth of pharmaceutical manufacturing activities, the essential requirement for formulation stability, and the regulatory endorsement of cellulose-based excipients.

The pharma grade cellulose powder market size is anticipated to experience substantial expansion in the coming years.

It is projected to reach $2.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%.

The observed growth during this forecast period can be attributed to the expansion in nutraceutical applications, a rising demand for clean-label excipients, the broadening of generic drug pipelines, advancements in excipient engineering, and increasing sustainability requirements.

Major trends expected in the forecast period include a growing demand for plant-based pharmaceutical excipients, increased application in solid oral dosage forms, the rising adoption of microcrystalline cellulose, the development of multi-functional cellulose excipients, and an increased focus on sustainable excipient sourcing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp

Which Drivers Are Expected To Impact The Pharma Grade Cellulose Powder Market During The Forecast Period?

The expanding pharmaceutical output is anticipated to fuel the growth of the pharma-grade cellulose powder market in the coming years. Pharmaceutical manufacturing encompasses the creation of medications through the formulation, synthesis, and quality control of active ingredients and excipients, ensuring their safety, effectiveness, and adherence to regulations. This increase in pharmaceutical production stems from the growing prevalence of chronic diseases, which necessitate consistent and long-term medication for effective management. Pharma-grade cellulose powder supports drug production by acting as a reliable binder, filler, and stabilizer, crucial for maintaining tablet structure and ensuring even distribution of active compounds. For instance, data from June 2023, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the European pharmaceutical industry, indicated that total pharmaceutical production in Europe reached $422,803 million (€390,000 million) in 2023, an increase from $393,857 million (€363,300 million) in 2022. Thus, the escalating pharmaceutical production is a key driver for the pharma-grade cellulose powder market’s expansion.

How Is The Pharma Grade Cellulose Powder Market Divided Into Segments?

The pharma grade cellulose powder market covered in this report is segmented –

1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)

2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent

3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications

4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries

Subsegments:

1) By Microcrystalline Cellulose: Powder, Granules

2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants

3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)

4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)

What Trends Are Expected To Impact The Competitive Landscape Of The Pharma Grade Cellulose Powder Market?

Major companies in the pharma-grade cellulose powder market are concentrating on establishing new microcrystalline cellulose facilities to expand their production capacity and strengthen their supply chain capabilities for pharmaceutical excipients. A microcrystalline cellulose facility is a specialized plant where purified cellulose undergoes precise chemical and mechanical processing to produce uniform, fine-grade particles for pharmaceutical applications. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturing company, unveiled Tabcell, India’s largest microcrystalline cellulose (MCC) manufacturing plant in Nagpur. This plant, featuring advanced technology and an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari and marks a significant milestone under the Government of India’s Production Linked Incentive (PLI) scheme for excipients. This new facility enhances Nitika Pharma’s position as a global leader in pharmaceutical excipients, supporting both domestic requirements and exports to over 92 countries, while also contributing to the “Make in India” initiative and fostering considerable local employment opportunities.

Which Leading Companies Dominate The Pharma Grade Cellulose Powder Market Share?

Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report

How Does The Pharma Grade Cellulose Powder Market Perform Across Major Global Regions?

North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharma Grade Cellulose Powder Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24373&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Cellulose Powder Market 2026, By The Business Research Company

Cellulose Gel Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-gel-global-market-report

Cellulose Acetate Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-acetate-global-market-report

Cellulose Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795